Cardiff Oncology Inc. (CRDF)
CRDF trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.01
-2.88% on the day
Market cap
$78.6M
Micro cap
Revenue · 2025
$593K
-13.2% on 2024
Net income · 2025
-$46K
-7.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CRDF on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001213037 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $593K |
| Net income | -$46K |
| Operating income | -$49.0M |
| Net margin | -7.7% |
| Operating margin | -8256.3% |
| Revenue growth | -13.2% |
| Cash | $17.5M |
| Total assets | $61.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 132.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-16 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-08-26 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PTHS | Pelthos Therapeutics Inc. | $20.29 | +3.94% | $77.7M |
| CGTX | Cognition Therapeutics Inc. | $0.8017 | -6.44% | $76.2M |
| OKYO | OKYO Pharma Limited | $1.44 | -0.17% | $75.4M |
| GRML | Greenland Mines Ltd. | $5.54 | -7.97% | $73.9M |
| NMRA | Neumora Therapeutics Inc. | $0.3702 | -15.34% | $69.6M |
| CSBR | Champions Oncology Inc. | $4.90 | -1.08% | $68.2M |
| ATRA | Atara Biotherapeutics Inc. | $9.30 | -0.80% | $93.4M |
| BDTX | Black Diamond Therapeutics Inc. | $1.68 | -5.08% | $96.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier